Insulet Corp

PODD: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|ZRLOCK|K^qZwLOCK|%$%r@LL$

Insulet Earnings: Stellar Growth Comes at Expense of Key Competitor

Insulet posted second-quarter revenue of $649 million, an increase of 31% in constant currency, with strong growth from both the US and international markets. Adjusted operating margin rose 670 basis points, driven primarily by lower sales and marketing expense.

Sponsor Center